Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the “Company”), today announced a $45 million strategic investment and partnership with MiCo Ltd more...
Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on Autoimmunity
– Company to present regarding AIM Biologic al s as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder (“NMOSD”), an orphan indication with strong unmet medical need TORONTO, ONTARIO, April 11, 2022 (GLOBE more...
PowerFleet Appoints Software Veteran Jim Zeitunian as Chief Technology Officer
Zeitunian will Lead PowerFleet’s Technology Strategy and Execution of SaaS-based Industrial/Fleet and Logistics Solutions WOODCLIFF LAKE, N.J., April 11, 2022 (GLOBE NEWSWIRE) — PowerFleet , Inc. (Nasdaq: PWFL), a global leader of Internet-of-Things (IoT) solutions more...
Oncocyte Presents Confirmatory Data for DetermaIO(TM) at the American Association for Cancer Research Annual Meeting 2022
Real-world cohort shows commercially available clinical test, DetermaIO, can predict response to immunotherapy and inform therapeutic decisions for patients with bladder cancer IRVINE, Calif., April 11, 2022 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a more...
Curis Announces FDA Partial Clinical Hold for TakeAim Lymphoma Study of Emavusertib (CA-4948)
Curis Announces FDA Partial Clinical Hold for TakeAim Lymphoma Study of Emavusertib (CA-4948) PR Newswire Curis voluntarily paused enrollment in this study earlier LEXINGTON, Mass. , April 11, 2022 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), more...
aTyr Pharma Presents Preclinical Research Characterizing Effects of ATYR2810 in Highly Aggressive Tumor Subtypes at the 2022 AACR Annual Meeting
Findings suggest that ATYR2810 reduces metastasis and enhances chemosensitivity by downregulating key genes linked to these processes. SAN DIEGO, April 11, 2022 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in more...
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Stock Jumps 24.5%: Will It Continue to Soar?
Bicycle Therapeutics PLC Sponsored ADR BCYC shares ended the last trading session 24.5% higher at $46.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This more...
Actinium Pharmaceuticals Highlights Potent Anti-Tumor Activity of a HER3 Targeted Radiotherapy at AACR
Actinium Pharmaceuticals Highlights Potent Anti-Tumor Activity of a HER3 Targeted Radiotherapy at AACR PR Newswire – Data show enhanced antitumor effects and improved survival were observed in a preclinical NSCLC model compared to a naked more...
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection
DEER PARK, Ill., April 11, 2022 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has received final approval more...
AnPac Bio and New Investor Sign Equity Investment Totaling $15 Million
PHILADELPHIA, April 11, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening more...